Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GB-102 in DME and RVO
NCT04085341Phase 2Completed
- Sponsor
- CalciMedica
- Start
- Sep 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GB-102 in diabetic macular edema (DME), retinal vein occlusion (RVO), sponsored by CalciMedica. Started Sep 2019; status: completed.
02
Drugs
GB-102
03
Conditions
diabetic macular edema (DME)retinal vein occlusion (RVO)
Beyond the preview
Go deeper on NCT04085341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04085341.